Type 1 Diabetes (T1D)
Market Overview
The global type 1 diabetes (T1D) market size was approximately USD 34.87 billion in 2024 and is projected to reach about USD 74.03 billion by 2034, demonstrating a compound annual growth rate (CAGR) of 7.82% during the period from 2024 to 2034.
Summary
Introduction to T1D
- Nature of the Disease: Type 1 diabetes (T1D) is an autoimmune disease.
- Pathological Mechanism: The immune system attacks and destroys the insulin-producing beta-cells in the pancreas, preventing the body from secreting sufficient insulin.
- Typical Onset Age: T1D is most commonly diagnosed in children and adolescents, but it can develop at any age.
- Primary Impact: Due to the lack of insulin, patients must rely on exogenous insulin therapy to maintain blood glucose balance.
Product Development Progress
